Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

被引：2

作者：

Bachet, Jean-Baptiste

Chibaudel, Benoist

Rakez, Manel

Goldberg, Richard M.

Tebbutt, Niall C.

Van Cutsem, Eric

Haller, Daniel G.

Hecht, J. Randolph Randolph

Mayer, Robert J.

Lichtman, Stuart M.

Benson, Al

Sobrero, Alberto F.

Tabernero, Josep

Adams, Richard

Zalcberg, John Raymond

Grothey, Axel

Yoshino, Takayuki

Shi, Qian

De Gramont, Aimery

机构：

[1] Hop La Pitie Salpetriere, Paris, France

[2] Franco British Inst, Levallois Perret, France

[3] ARCAD Fdn, Stat Unit, Levallois Perret, France

[4] West Virginia Univ, Inst Canc, Morgantown, WV 26506 USA

[5] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Heidelberg, Vic, Australia

[6] Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Katholieke Univ Leuven, Leuven, Belgium

[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[12] Northwestern Med, Chicago, IL USA

[13] IRCCS Osped Policlin San Martino, Genoa, Italy

[14] Vall dHebron Univ Hosp, Barcelona, Spain

[15] UVic UCC, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[16] Cardiff Univ, Cardiff, Wales

[17] Velindre Canc Ctr, Cardiff, Wales

[18] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] West Canc Ctr, OneOncol, Germantown, TN USA

[20] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[21] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3575

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3575

引用

页数：3

共 50 条

[21] Toxicity and efficacy of 1st line cetuximab (cetux)-based therapy in RAS wildtype (WT) older patients (pts) with metastatic colorectal cancer (mCRC): A pooled analysis from 1,274 pts in the ARCAD database
Papamichael, D.
Lopes, G. S.
Olswold, C. L.
Chibaudel, B.
Zalcberg, J. R.
Van Cutsem, E.
Venook, A.
Maughan, T.
Heinemann, V.
Kaplan, R. S.
Bokemeyer, C.
Lenz, H. J.
Yoshino, T.
Adams, R. A.
Grothey, A.
De Gramont, A.
Shi, Q.
ANNALS OF ONCOLOGY, 2020, 31 : S425 - S425
[22] Response to epithelial growth factor receptor inhibitor (EGFRi) treatment in patients with early-onset, treatment-naive metastatic colorectal cancer (mCRC): An ARCAD database analysis.
Jin, Zhaohui
Dixon, Jesse G.
Hubbard, Joleen M.
Eng, Cathy
Lieu, Christopher Hanyoung
Douillard, Jean-Yves
Adams, Richard
Maughan, Timothy S.
Van Cutsem, Eric
Venook, Alan P.
Lenz, Heinz-Josef
Heinemann, Volker
Stintzing, Sebastian
Kaplan, Richard S.
Bokemeyer, Carsten
Chibaudel, Benoist
Zalcberg, John Raymond
Yoshino, Takayuki
De Gramont, Aimery
Shi, Qian
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[23] Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
Yin, Jun
Dawood, Shaheenah
Cohen, Romain
Meyers, Jeff
Zalcberg, John
Yoshino, Takayuki
Seymour, Matthew
Maughan, Tim
Saltz, Leonard
Van Cutsem, Eric
Venook, Alan
Schmoll, Hans-Joachim
Goldberg, Richard
Hoff, Paulo
Hecht, J. Randolph
Hurwitz, Herbert
Punt, Cornelis
Diaz Rubio, Eduard
Koopman, Miriam
Cremolini, Chiara
Heinemann, Volker
Tournigard, Christophe
Bokemeyer, Carsten
Fuchs, Charles
Tebbutt, Niall
Souglakos, John
Doulliard, Jean-Yves
Kabbinavar, Fairooz
Chibaudel, Benoist
de Gramont, Aimery
Shi, Qian
Grothey, Axel
Adams, Richard
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[24] Extended RAS analysis in patients (pts) with untreated metastatic colorectal cancer (mCRC): Results from the PRIME and PEAK studies
Hecht, J. Randolph
Douillard, Jean-Yves
Schwartzberg, Lee
Siena, Salvatore
Tabernero, Josep
Karthaus, Meinholf
Rivera, Fernando
Oliner, Kelly S.
Yu, Hua
Tian, Ying
Jung, Scott
Go, Will
MOLECULAR CANCER RESEARCH, 2014, 12
[25] Efficacy of bevacizumab-based treatment in early-onset treatment-naive metastatic colorectal cancer patients: An ARCAD database analysis
Jin, Zhaohui
Dixon, Jesse G.
Hubbard, Joleen M.
Eng, Cathy
Lieu, Christopher Hanyoung
Fiskum, Jack
Saltz, Leonard B.
Hurwitz, Herbert I.
Venook, Alan P.
Schmoll, Hans-Joachim
Fuchs, Charles S.
Hecht, J. Randolph Randolph
Cremolini, Chiara
Diaz-Rubio, Eduardo
Punt, Cornelis J. A.
Tebbutt, Niall C.
Heinemann, Volker
Yoshino, Takayuki
De Gramont, Aimery
Shi, Qian
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[26] Treatment (T) of metastatic colorectal cancer (mCRC) patients (pts) ≥75 years (y) old in clinical practice: A multicenter analysis
Grande, Roberta
Garufi, Carlo
Pavese, Ida
Ciancola, Fabrizio
Gamma, Donatello
Pellegrino, Arianna
Di Lauro, Luigi
Corsi, Domenico C.
Signorelli, Diego
Sperduti, Isabella
Cortese, Giada
Risi, Emanuela
Moreno, Federica
Sergi, Domenico
Signorelli, Carlo
Natoli, Clara
Ruggeri, Enzo
Zampa, Germano
Russano, Marco
Gamucci, Teresa
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[27] The prognostic role of metastatic lymph node ratio-staging system in gastric cancer patients: Analysis of the National Cancer Database.
Naffouje, Rand
Salti, George I.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[28] Bevacizumab (Bev)-based combinations across treatment lines in patients (pts) with metastatic colorectal cancer (mCRC) - interim results from a German non-interventional study (KORALLE)
Eggers, E.
Uhlig, J.
Reichert, D.
Wein, A.
Schulz, H.
Beringer, A.
Arnold, D.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 162 - +
[29] Analysis of potential predictive factors of clinical benefit in patients (pts) with metastatic colorectal cancer (MCRC) treated with single-agent cetuximab as first-line treatment
Gravalos, C.
Sastre, J.
Aranda, E.
Massuti, B.
Vega-Villegas, M. E.
Gomez, A.
Varella-Garcia, M.
Jimeno, A.
Diaz-Rubio, E.
Hidalgo, M.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[30] The Role of Bevacizumab (B) in the Maintenance Treatment After Chemotherapy (CT) for Metastatic Colorectal Cancer (mCRC) Patients (pts) - an Italian Multicenter Retrospective Analysis
Moscetti, L.
Fabbri, A.
Pochesci, A.
Alesini, D.
Gemma, D.
Grande, R.
Pavese, I.
Sperduti, I.
Franco, D.
Ruggeri, E. M.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S429 - S429

← 1 2 3 4 5 →